Yutaro Otsuka
Sapporo, 0608638, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 11, 2019
Brain-Derived Neurotrophic Factor Improves Limited Exercise Capacity in Mice With Heart Failure.
Journal: Circulation
Published: October 30, 2018
Small-conductance Ca2+-activated K+ channel activation deteriorates hypoxic ventricular arrhythmias via CaMKII in cardiac hypertrophy.
Journal: American journal of physiology. Heart and circulatory physiology
Published: April 11, 2018
p53-Dependent and -Independent Epithelial Integrity: Beyond miRNAs and Metabolic Fluctuations.
Journal: Cancers
Published: April 03, 2018
Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
Journal: Cell communication and signaling : CCS
Published: August 31, 2017
Necessity of p53-binding to the CDH1 locus for its expression defines two epithelial cell types differing in their integrity.
Journal: Scientific reports
Published: August 22, 2017
High expression of EPB41L5, an integral component of the Arf6-driven mesenchymal program, correlates with poor prognosis of squamous cell carcinoma of the tongue.
Journal: Cell communication and signaling : CCS
Published: September 06, 2016
P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance.
Journal: The Journal of cell biology
Published: October 01, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026